X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (40773) 40773
Newsletter (2358) 2358
Newspaper Article (1068) 1068
Book Chapter (257) 257
Magazine Article (217) 217
Dissertation (184) 184
Transcript (49) 49
Book / eBook (43) 43
Publication (43) 43
Conference Proceeding (36) 36
Government Document (33) 33
Web Resource (21) 21
Reference (11) 11
Book Review (4) 4
Journal / eJournal (3) 3
Paper (3) 3
Report (2) 2
Streaming Video (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24896) 24896
erythropoietin (22761) 22761
male (12144) 12144
female (11537) 11537
animals (11403) 11403
anemia (8464) 8464
erythropoietin - therapeutic use (7826) 7826
middle aged (6793) 6793
adult (6243) 6243
mice (5478) 5478
recombinant proteins (5126) 5126
aged (5051) 5051
recombinant-human-erythropoietin (4914) 4914
erythropoietin - pharmacology (4902) 4902
hematology (4592) 4592
urology & nephrology (4344) 4344
anemia - drug therapy (4195) 4195
anemia - etiology (4064) 4064
erythropoietin - administration & dosage (3483) 3483
rats (3431) 3431
research (3329) 3329
erythropoietin - blood (3208) 3208
erythropoiesis (2857) 2857
hematocrit (2678) 2678
expression (2665) 2665
oncology (2565) 2565
erythropoietin - metabolism (2489) 2489
biochemistry & molecular biology (2457) 2457
renal dialysis (2396) 2396
hemoglobin (2336) 2336
kidney failure, chronic - complications (2315) 2315
hypoxia (2274) 2274
kidney failure, chronic - therapy (2173) 2173
treatment outcome (2165) 2165
analysis (2138) 2138
time factors (2095) 2095
hemodialysis (2079) 2079
cells, cultured (2045) 2045
anemia - blood (2041) 2041
hemoglobins - analysis (1917) 1917
pharmacology & pharmacy (1911) 1911
cancer (1863) 1863
therapy (1833) 1833
recombinant proteins - therapeutic use (1830) 1830
medicine, research & experimental (1828) 1828
epoetin alfa (1796) 1796
apoptosis (1776) 1776
transplantation (1773) 1773
care and treatment (1770) 1770
medicine, general & internal (1769) 1769
erythropoietin - adverse effects (1729) 1729
cell biology (1716) 1716
cells (1695) 1695
erythropoietin - genetics (1647) 1647
hemoglobins - metabolism (1602) 1602
health aspects (1573) 1573
aged, 80 and over (1553) 1553
erythropoietin - biosynthesis (1541) 1541
adolescent (1531) 1531
erythropoiesis - drug effects (1530) 1530
erythropoietin receptor (1525) 1525
blood transfusion (1514) 1514
anemia - therapy (1513) 1513
hematinics - therapeutic use (1506) 1506
risk factors (1492) 1492
mortality (1488) 1488
erythropoietin, recombinant (1480) 1480
dose-response relationship, drug (1471) 1471
signal transduction (1383) 1383
disease (1382) 1382
cell line (1375) 1375
proteins (1347) 1347
surgery (1345) 1345
hemodialysis-patients (1344) 1344
iron (1303) 1303
physiological aspects (1270) 1270
prospective studies (1260) 1260
receptor (1246) 1246
pediatrics (1235) 1235
activation (1217) 1217
gene expression (1216) 1216
inflammation (1211) 1211
erythropoietin - physiology (1208) 1208
growth factors (1203) 1203
infant, newborn (1202) 1202
colony-stimulating factor (1195) 1195
glycoproteins (1155) 1155
erythropoietin - analogs & derivatives (1152) 1152
anaemia (1126) 1126
kidney failure, chronic - blood (1120) 1120
double-blind (1110) 1110
neurosciences (1105) 1105
blood (1104) 1104
quality of life (1077) 1077
retrospective studies (1077) 1077
receptors, erythropoietin - metabolism (1076) 1076
molecular sequence data (1071) 1071
physiology (1062) 1062
darbepoetin alfa (1056) 1056
medical research (1036) 1036
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (20) 20
Online Resources - Online (18) 18
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
UofT at Mississauga - Stacks (3) 3
University Archives - Archives (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Reference (1) 1
Gerstein Science - Theses (1) 1
OISE - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (41080) 41080
German (750) 750
French (747) 747
Japanese (710) 710
Spanish (563) 563
Russian (453) 453
Chinese (298) 298
Polish (297) 297
Italian (231) 231
Czech (98) 98
Korean (86) 86
Portuguese (83) 83
Hungarian (40) 40
Turkish (40) 40
Dutch (26) 26
Croatian (25) 25
Serbian (23) 23
Danish (21) 21
Swedish (16) 16
Bulgarian (15) 15
Norwegian (15) 15
Romanian (14) 14
Persian (12) 12
Finnish (10) 10
Slovak (8) 8
Hebrew (6) 6
Slovenian (5) 5
Ukrainian (5) 5
Arabic (2) 2
Bosnian (2) 2
Icelandic (1) 1
Indonesian (1) 1
Lithuanian (1) 1
Macedonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroscience, ISSN 0270-6474, 01/2006, Volume 26, Issue 4, pp. 1269 - 1274
Journal Article
Cell (Cambridge), ISSN 0092-8674, 2017, Volume 168, Issue 6, pp. 1053 - 1064.e15
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 13, pp. 1210 - 1219
In this trial, patients with systolic heart failure and anemia were assigned to receive either darbepoetin alfa or placebo. At 28 months, there was no... 
MORTALITY | CONTROLLED-TRIAL | CITY CARDIOMYOPATHY QUESTIONNAIRE | EPOETIN | MORBIDITY | REDUCTION | DOUBLE-BLIND | CHRONIC KIDNEY-DISEASE | MEDICINE, GENERAL & INTERNAL | Shock, Septic - etiology | Double-Blind Method | Heart Failure, Systolic - drug therapy | Hematinics - therapeutic use | Erythropoietin - therapeutic use | Heart Failure, Systolic - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Erythropoietin - adverse effects | Hematinics - adverse effects | Male | Thromboembolism - etiology | Erythropoietin - analogs & derivatives | Stroke - etiology | Anemia - drug therapy | Treatment Failure | Female | Aged | Darbepoetin alfa | Anemia - etiology | Hemoglobins - analysis | Heart Failure, Systolic - complications | Heart failure | Usage | Care and treatment | Anemia | Patient outcomes | Diagnosis | Clinical trials | Patient safety | Hemoglobin | Thromboembolism | Patients | Heart diseases | Cancer | Shock | Systolic/mortality | Hematinics/adverse effects | chronic heart failure | Erythropoietin/analogs & derivatives | Thromboembolism/etiology | Klinisk medicin | Heart Failure | Anemia/drug therapy | Hematinics/therapeutic use | Erythropoietin/therapeutic use | Hemoglobins/analysis | Anemia/etiology | Erythropoietin/adverse effects | Stroke/etiology | Clinical Medicine | Systolic/complications | Septic/etiology | Systolic/drug therapy
Journal Article
Neurotherapeutics, ISSN 1878-7479, 2009, Volume 6, Issue 1, pp. 108 - 127
The growth factor erythropoietin (EPO) and erythropoietin receptors (EPOR) are expressed in the nervous system. Neuronal expression of EPO and EPOR peaks... 
hematocrit | thrombocytes | motor function | Ischemia | cognition | safety | Neurology | Neurosciences | Biomedicine | Neurobiology | Neurosurgery | RECOMBINANT-HUMAN-ERYTHROPOIETIN | ANEURYSMAL SUBARACHNOID HEMORRHAGE | CANCER-ASSOCIATED ANEMIA | FOCAL CEREBRAL-ISCHEMIA | HIGH-DOSE ERYTHROPOIETIN | NEUROSCIENCES | CLINICAL NEUROLOGY | PROGRESSIVE MULTIPLE-SCLEROSIS | REDUCES NEURONAL APOPTOSIS | TRAUMATIC BRAIN-INJURY | PHARMACOLOGY & PHARMACY | NEONATAL HYPOXIA-ISCHEMIA | RED-CELL APLASIA | Neuroprotective Agents - therapeutic use | Brain Diseases - metabolism | Schizophrenia - metabolism | Spinal Cord Injuries - drug therapy | Spinal Cord Injuries - metabolism | Erythropoietin - therapeutic use | Humans | Erythropoietin - adverse effects | Retinal Diseases - metabolism | Stroke - drug therapy | Neurodegenerative Diseases - metabolism | Neurodegenerative Diseases - drug therapy | Peripheral Nerves - drug effects | Erythropoietin - analogs & derivatives | Brain Diseases - drug therapy | Stroke - metabolism | Animals | Nervous System - drug effects | Signal Transduction - drug effects | Receptors, Erythropoietin - drug effects | Erythropoietin - metabolism | Retinal Diseases - drug therapy | Schizophrenia - drug therapy | Neurons - drug effects | Nervous system diseases | Multiple sclerosis | Erythropoietin | Analysis | Schizophrenia | Cognition | Health aspects | Medical research | Nervous system | Review
Journal Article